Pontifax Management 4 G.P. (2015) Ltd. - 10%+ Owner at Keros Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
KROS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Pontifax Management 4 G.P. (2015) Ltd. since 9/17/2023

Holdings reported by Pontifax Management 4 G.P. (2015) Ltd. for Keros Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.23M $55.5M $45.29 Nov 29, 2022 Indirect
Call Options (obligation to sell) 0 Nov 29, 2022 Indirect Common Stock

Transactions reported by Pontifax Management 4 G.P. (2015) Ltd. for Keros Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.